| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LOXO ONCOLOGY INC COM | 4,028,920 | 93,390,000 | 22.05% | ||
| 2 | ZELTIQ AESTHETICS INCORPORATED | 2,109,727 | 57,659,000 | 13.62% | ||
| 3 | AIMMUNE THERAPEUTICS INC COM | 2,990,000 | 32,352,000 | 7.64% | ||
| 4 | VIEWRAY INC | 7,461,923 | 30,519,000 | 7.21% | ||
| 5 | VERSARTIS INC COM | 2,279,568 | 25,212,000 | 5.95% | ||
| 6 | T2 BIOSYSTEMS INC | 2,830,992 | 22,337,000 | 5.27% | ||
| 7 | ADMA BIOLOGICS, INC. | 3,608,171 | 21,469,000 | 5.07% | ||
| 8 | CEMPRA INC | 1,193,060 | 19,674,000 | 4.65% | ||
| 9 | Agile Therapeutics, Inc. | 2,583,797 | 19,663,000 | 4.64% | ||
| 10 | CYNAPSUS THERAPEUTICS INC | 1,021,381 | 17,108,000 | 4.04% | ||
| 11 | SYROS PHARMACEUTICALS INC | 908,565 | 16,490,000 | 3.89% | ||
| 12 | Esperion Therapeutics Inc | 1,637,125 | 16,175,000 | 3.82% | ||
| 13 | CATALENT INC | 472,781 | 10,869,000 | 2.57% | ||
| 14 | CIDARA THERAPEUTICS INC | 1,021,148 | 10,528,000 | 2.49% | ||
| 15 | TRANSENTERIX INC | 8,335,819 | 10,170,000 | 2.40% | ||
| 16 | PARATEK PHARMACEUTICALS INC | 482,680 | 6,714,000 | 1.59% | ||
| 17 | Intersect ENT Inc | 450,000 | 5,819,000 | 1.37% | ||
| 18 | DERMIRA INC | 102,593 | 3,001,000 | 0.71% | ||
| 19 | CHIMERIX INC | 472,943 | 1,859,000 | 0.44% | ||
| 20 | LOMBARD MEDICAL INC | 886,363 | 966,000 | 0.23% | ||
| 21 | PERNIX THERAPEUTICS HLDGS IN | 2,010,000 | 905,000 | 0.21% | ||
| 22 | PERNIX THERAPEUTICS HOLDINGS INC | 2,500,000 | 575,000 | 0.14% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950142-16-004305, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
